Macrophage-specific silencing of SMAD3 effectively blocks macrophage–myofibroblast transition (MMT), thereby inhibiting cancer-associated fibroblasts (CAF)-mediated cancer progression [26]. This evidence concerns the gene SMAD3 and cancer.